Bibliographic information

Guideline
Year of Publication
Issuing Institution

Recommendation

New

WHO suggests for the use of tranexamic acid in patients with confirmed filovirus disease and postpartum haemorrhage.

Recommended in favor

Conditional

Notes and Remarks

  • Employ standard care protocols for postpartum haemorrhage, including a uterotonic (oxytocin is preferred where available). • Tranexamic acid should be given intravenously within 3 hours of birth.